These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31803485)

  • 21. Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES).
    Aslamy A; Wood AC; Jensen ET; Bertoni AG; Sheridan PA; Wong KE; Ramesh G; Rotter JI; Chen YI; Goodarzi MO
    Diabetes; 2024 Mar; 73(3):385-390. PubMed ID: 37992186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement factor 3 is associated with insulin resistance and with incident type 2 diabetes over a 7-year follow-up period: the CODAM Study.
    Wlazlo N; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schalkwijk CG; Bravenboer B; Stehouwer CD
    Diabetes Care; 2014 Jul; 37(7):1900-9. PubMed ID: 24760264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
    Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
    Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of particular glucose transporters and insulin resistance indicators in the risk groups of type 2 diabetes--a two-year follow-up.
    Bernat-Karpińska M; Piątkiewicz P; Czech A; Wierzbicki P
    Endokrynol Pol; 2012; 63(3):212-9. PubMed ID: 22744628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances.
    Florez H; Ryder E; Campos G; Fernandez V; Morales LM; Valbuena H; Rincón E; Gómez ME; Raleigh X
    Invest Clin; 1999 Jun; 40(2):127-42. PubMed ID: 10390951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance.
    Catalano PM; Drago NM; Amini SB
    Diabetes Care; 1998 Mar; 21(3):403-8. PubMed ID: 9540023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-hour post-load plasma glucose predicts progression to prediabetes in a multi-ethnic cohort of obese youths.
    Tricò D; Galderisi A; Mari A; Santoro N; Caprio S
    Diabetes Obes Metab; 2019 May; 21(5):1191-1198. PubMed ID: 30663201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Obex in Overweight and Obese Subjects With or Without Impaired Fasting Glucose: A Pilot Study.
    Cabrera-Rode E; Rodríguez J; Álvarez A; Echevarría R; Reyes AD; Cubas-Dueñas I; Turcios-Tristá SE; Díaz-Díaz O
    J Diet Suppl; 2017 Nov; 14(6):626-639. PubMed ID: 28384000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior lactation reduces future diabetic risk through sustained postweaning effects on insulin sensitivity.
    Bajaj H; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E215-E223. PubMed ID: 27965206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid and lipid metabolism in post-gestational diabetes and progression to type 2 diabetes: A metabolic profiling study.
    Lai M; Liu Y; Ronnett GV; Wu A; Cox BJ; Dai FF; Röst HL; Gunderson EP; Wheeler MB
    PLoS Med; 2020 May; 17(5):e1003112. PubMed ID: 32433647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.
    Thamer C; Haap M; Heller E; Joel L; Braun S; Tschritter O; Haring H; Fritsche A
    Horm Metab Res; 2006 Mar; 38(3):178-82. PubMed ID: 16673209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
    Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
    Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
    J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertriglyceridaemic waist phenotype as a simple predictive marker of incident diabetes in Asian-Indian men with prediabetes.
    Ram J; Snehalatha C; Nanditha A; Selvam S; Shetty SA; Godsland IF; Johnston DG; Ramachandran A
    Diabet Med; 2014 Dec; 31(12):1542-9. PubMed ID: 24910196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nateglinide on the secretion of glycated insulin and glucose tolerance in type 2 diabetes.
    Lindsay JR; McKillop AM; Mooney MH; O'Harte FP; Flatt PR; Bell PM
    Diabetes Res Clin Pract; 2003 Sep; 61(3):167-73. PubMed ID: 12965106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.
    Mari A; Gastaldelli A; Foley JE; Pratley RE; Ferrannini E
    Diabetes Care; 2005 May; 28(5):1132-8. PubMed ID: 15855578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes.
    Harrison LC; Honeyman MC; Steele CE; Stone NL; Sarugeri E; Bonifacio E; Couper JJ; Colman PG
    Diabetes Care; 2004 Oct; 27(10):2348-55. PubMed ID: 15451899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.